ArticleLeukemia research reports2025

Corrigendum to "First-line therapy with daratumumab, lenalidomide and dexamethasone for patient with POEMS syndrome: A case report" [Leukemia Research Reports (2024) Volume 22, 100491].

E Amabile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.